| Name | Seabury |
|---|---|
| Location | 200 Seabury Drive, Bloomfield, Connecticut |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 72 |
| Occupancy Rate | 73.75% |
| Medicare ID (CCN) | 075383 |
| Legal Business Name | Church Home Of Hartford, Inc |
| Ownership Type | Non Profit - Church Related |
| NPI Number | 1285690925 |
| Organization Name | CHURCH HOME OF HARTFORD, INC |
| Doing Business As | SEABURY |
| Address | 200 Seabury Drive, Bloomfield, CT 06002 |
| Phone Number | 860-286-0243 |
News Archive
Scientists hoping to find new treatments for one of the world's most deadly infectious diseases say drugs used to treat common fungal infections may provide the answer.
Research by scientists at King's College London into the role the gut plays in processing and distributing fat could pave the way for the development of personalized treatments for obesity and other chronic diseases within the next decade.
The WHO's decision Thursday to declare H1N1 (swine) flu a pandemic will "speed the production of a vaccine against the new virus," however scientists continue to caution that "it will be fall at the earliest before the first doses are available," the Los Angeles Times reports.
Vycor Medical, Inc., a medical device company that designs, develops and markets next generation neurosurgery retraction devices, today announced its ViewSite Brain Access System (VBAS) medical retraction device continues to gain ground. This "BioTech Breakthrough" - with the potential to impact several hundreds of thousands of patients and throngs of surgeons and medical facilities worldwide - is among a pioneering new breed of cost-reducing surgical devices designed to enhance performance, quality of life and surgical results.
› Verified 7 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Scientists hoping to find new treatments for one of the world's most deadly infectious diseases say drugs used to treat common fungal infections may provide the answer.
Research by scientists at King's College London into the role the gut plays in processing and distributing fat could pave the way for the development of personalized treatments for obesity and other chronic diseases within the next decade.
The WHO's decision Thursday to declare H1N1 (swine) flu a pandemic will "speed the production of a vaccine against the new virus," however scientists continue to caution that "it will be fall at the earliest before the first doses are available," the Los Angeles Times reports.
Vycor Medical, Inc., a medical device company that designs, develops and markets next generation neurosurgery retraction devices, today announced its ViewSite Brain Access System (VBAS) medical retraction device continues to gain ground. This "BioTech Breakthrough" - with the potential to impact several hundreds of thousands of patients and throngs of surgeons and medical facilities worldwide - is among a pioneering new breed of cost-reducing surgical devices designed to enhance performance, quality of life and surgical results.
› Verified 7 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 25.9 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 13.64 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 64.29 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.42 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 4.05 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 52.17 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 10.06 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 85.8 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 19.53 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 59.36 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 2.22 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 48.63 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 19.74 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 5.47 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 96.43 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 79.42 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 72.78 | 82.93 |
News Archive
Scientists hoping to find new treatments for one of the world's most deadly infectious diseases say drugs used to treat common fungal infections may provide the answer.
Research by scientists at King's College London into the role the gut plays in processing and distributing fat could pave the way for the development of personalized treatments for obesity and other chronic diseases within the next decade.
The WHO's decision Thursday to declare H1N1 (swine) flu a pandemic will "speed the production of a vaccine against the new virus," however scientists continue to caution that "it will be fall at the earliest before the first doses are available," the Los Angeles Times reports.
Vycor Medical, Inc., a medical device company that designs, develops and markets next generation neurosurgery retraction devices, today announced its ViewSite Brain Access System (VBAS) medical retraction device continues to gain ground. This "BioTech Breakthrough" - with the potential to impact several hundreds of thousands of patients and throngs of surgeons and medical facilities worldwide - is among a pioneering new breed of cost-reducing surgical devices designed to enhance performance, quality of life and surgical results.
› Verified 7 days ago
Bloomfield Health Care Center Location: 355 Park Avenue, Bloomfield, Connecticut 06002 Phone: (860) 242-8595 | |
Caleb Hitchcock Health Care Ce Location: 40 Loeffler Rd, Bloomfield, Connecticut 06002 Phone: (860) 726-2000 | |